Search Results - "Myong Cheol Lim"

Association between the location of transposed ovary and ovarian function in patients with uterine cervical cancer treated with (postoperative or primary) pelvic radiotherapy by Hwang, Jong Ha, M.D., Ph.D, Yoo, Heon Jong, M.D, Park, Sae Hyun, M.D, Lim, Myong Cheol, M.D., Ph.D, Seo, Sang-Soo, M.D., Ph.D, Kang, Sokbom, M.D., Ph.D, Kim, Joo-Young, M.D., Ph.D, Park, Sang-Yoon, M.D., Ph.D

“…Objective To evaluate the effectiveness of ovarian transposition procedures in preserving ovarian function in relation to the location of the transposed…”
Get full text

Preoperative laboratory parameters associated with deep vein thrombosis in patients with ovarian cancer: retrospective analysis of 3,147 patients in a single institute by Hyoeun Shim, Yeon Jee Lee, Ji Hyun Kim, Myong Cheol Lim, Dong-eun Lee, Sang Yoon Park, Sun-young Kong

“…Objective: Patients with ovarian cancer have a high risk of developing thrombosis. We aimed to investigate laboratory parameters associated with deep vein…”
Get full text

Trends in the incidence and survival outcomes of endometrial cancer in Korea: a nationwide population-based cohort study by Seung-hyuk Shim, Jiwon Lim, Ji Hyun Kim, Yeon Jee Lee, Hyeong In Ha, Myong Cheol Lim, Young-joo Won

“…Objective: To evaluate trends in the incidence and survival outcomes of endometrial cancer (EC) based on the year of diagnosis, stage, age, and histologic…”
Get full text

Incidence and survival rates of primary uterine carcinosarcoma in Korea: a National Cancer Registry study by Se Ik Kim, Ji Hyun Kim, Cheol Lee, Johyun Ha, Kyu-won Jung, Myong Cheol Lim

“…Objective: To investigate the incidence and survival rates of primary uterine carcinosarcoma (UCS) in Korea. Methods: From the Korea Central Cancer Registry,…”
Get full text

Incidence and treatment outcomes of ovarian carcinosarcoma from the national cancer registry of Korea by Hyeong In Ha, Ji Hyun Kim, Jiwon Lim, Yong Jung Song, Young-joo Won, Myong Cheol Lim

“…Objective: To investigate the incidence and survival outcomes of ovarian carcinosarcoma in Korea between 1999 and 2018. Methods: Patients diagnosed with…”
Get full text

Ten-year treatment outcomes of consolidation hyperthermic intraperitoneal chemotherapy for ovarian cancer (HIPEC-KOV-03R) by Ji Geun Yoo, Ji Hyun Kim, Eun Young Park, Imhyeon Kim, Myong Cheol Lim, Sung Jong Lee

“…Objective: We aimed to evaluate the long-term efficacy of consolidation hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with primary epithelial…”
Get full text

Incidence and treatment outcomes of uterine cervical cancer in Korea 1999-2018 from the national cancer registry by Dong Hoon Suh, Hyeong In Ha, Yeon Jee Lee, Jiwon Lim, Young-joo Won, Myong Cheol Lim

“…Objective: To describe the incidence and survival outcomes of uterine cervical cancer during 1999-2018. Methods: Patients who were diagnosed with cervical…”
Get full text

Adherence of PARP inhibitor for frontline maintenance therapy in primary epithelial ovarian cancer: a cross-sectional survey by Ji Hyun Kim, Yumi Lee, Da-young Kim, Sinae Kim, Sang-soo Seo, Sokbom Kang, Sang-yoon Park, Myong Cheol Lim

“…Objective: To identify the adherence rate to poly (ADP-ribose) polymerase (PARP) inhibitors and identify factors contributing to the deterioration of adherence…”
Get full text

Impact of metformin on survival outcome in ovarian cancer: a nationwide population-based cohort study by Jeong-yeol Park, Myong Cheol Lim, Min-hyun Baek, Young-han Park, Seonok Kim

“…Objective: Investigation of new drugs (INDs) is a tremendously inefficient process in terms of time and cost. Drug repositioning is another method used to…”
Get full text

Role and clinical application of next-generation sequencing (NGS) for ovarian cancer by Myong Cheol Lim, Leslie M. Randall

Get full text

Peritoneal cancer index in ovarian cancer by Wonkyo Shin, Sang-yoon Park, Myong Cheol Lim

Get full text

Cause-specific mortality rate of ovarian cancer in the presence of competing risks of death: a nationwide population-based cohort study by Seung-hyuk Shim, Myong Cheol Lim, Dahhay Lee, Young-joo Won, Hyeong In Ha, Ha Kyun Chang, Hyunsoon Cho

“…Objective: This nationwide cohort study aimed to evaluate the cause-specific mortality (probability of death by ovarian cancer, probability of death by other…”
Get full text

Reclassification of BRCA1 and BRCA2 variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers by Hyeong In Ha, Jin-sun Ryu, Hyoeun Shim, Sun-young Kong, Myong Cheol Lim

“…Objective: We investigated the proportions of and reclassified BRCA1/2 variants of unknown significance (VUS) in Korean patients with epithelial ovarian,…”
Get full text

Determination of ovarian transposition through prediction of postoperative adjuvant therapy in young patients with early stage cervical cancer undergoing surgery: a Korean multicenter retrospective study (KGOG 1042) by Woo Yeon Hwang, Chel Hun Choi, Kidong Kim, Moon-hong Kim, Myong Cheol Lim, Banghyun Lee, Myounghwan Kim, Yun Hwan Kim, Seok Ju Seong, Jong-min Lee

“…Objective We aimed to predict the risk of postoperative adjuvant therapy using preoperative variables in young patients with early stage cervical cancer. The…”
Get full text

Effect of Pap smear screening on cervical cancer stage at diagnosis: results from the Korean National Cancer Screening Program by Cam Nhung Bui, Seri Hong, Mina Suh, Jae Kwan Jun, Kyu Won Jung, Myong Cheol Lim, Kui Son Choi

“…Objective: We aimed to determine the differences in stage at diagnosis of cervical cancer among Korean women according to screening history. Methods: Using…”
Get full text

Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines by Banghyun Lee, Suk-joon Chang, Byung Su Kwon, Joo-hyuk Son, Myong Cheol Lim, Yun Hwan Kim, Shin-wha Lee, Chel Hun Choi, Kyung Jin Eoh, Jung-yun Lee, Dong Hoon Suh, Yong Beom Kim

“…Since the latest practice guidelines for ovarian cancer were developed by the Korean Society of Gynecologic Oncology (KSGO) in 2021, many studies have examined…”
Get full text

Incidence trends for epithelial peritoneal, ovarian, and fallopian tube cancer during 1999-2016: a retrospective study based on the Korean National Cancer Incidence Database by Wonkyo Shin, Young Joo Won, Chong Woo Yoo, Jiwon Lim, Myong Cheol Lim

“…Objective: Primary peritoneal cancer (PPC), ovarian cancer (OC), and fallopian tube cancer (FTC) are considered as a single disease group. As knowledge of the…”
Get full text

Quality of life outcomes from the randomized trial of hyperthermic intraperitoneal chemotherapy following cytoreductive surgery for primary ovarian cancer (KOV-HIPEC-01) by Ji Hyun Kim, Dong-eun Lee, Yumi Lee, Hyeong In Ha, Yoon Jung Chang, Suk-joon Chang, Sang-yoon Park, Myong Cheol Lim

“…Objective: To investigate the health-related quality of life (HRQOL) related to hyperthermic intraperitoneal chemotherapy (HIPEC) following primary or interval…”
Get full text

Correction of Funding information: The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry by Hyeong In Ha, Ha Kyun Chang, Soo Jin Park, Jiwon Lim, Young-joo Won, Myong Cheol Lim

Get full text

A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial by Junsik Park, Myong Cheol Lim, Jae-kwan Lee, Dae Hoon Jeong, Se Ik Kim, Min Chul Choi, Byoung-gie Kim, Jung-yun Lee

“…Background: Given the expanding clinical use of poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitors (PARPis), there is a significant need for…”
Get full text